HY-10228-50mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-10228-1mL
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-123593-10mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
HY-123593-100mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
HY-123593-5mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
HY-123593-50mg
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9]
|
|
Cancer-programmed cell death
|
|
HY-123593-1mL
|
MedChemexpress LLC
|
Mozavaptan (hydrochloride) [CAS 138470-70-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-18346-10mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-100mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-5mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-50mg
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5]
|
|
Cancer-programmed cell death
|
|
HY-18346-1mL
|
MedChemexpress LLC
|
Mozavaptan [CAS 137975-06-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
M314360-5g
|
Toronto Research Chemicals
|
2-Methylisoindole-1,3-dione [CAS 550-44-7]
|
|
|
|
M314360-25g
|
Toronto Research Chemicals
|
2-Methylisoindole-1,3-dione [CAS 550-44-7]
|
|
|
|